Alloimmune T-Cell Responses in Highly Sensitized Kidney Transplant Recipients


About this study

The purpose of this study is to better understand how the immune system reacts to kidney transplantation in individuals who are potentially at higher risk for rejection.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Kidney transplant candidate with planned transplant.

Exclusion Criteria: 

  • Donor-recipient pair in kidney paired donation.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Carrie Schinstock, M.D.

Closed for enrollment

Contact information:

Nong Braaten L.P.N.


Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

SangKon Oh, Ph.D.

Closed for enrollment

Contact information:

HyeMee Joo Ph.D.


More information


Publications are currently not available

Mayo Clinic Footer